Microbot Medical Inc. (MBOT) financial statements (2021 and earlier)

Company profile

Business Address 175 DERBY ST. 27/1
HINGHAM, MA 02043
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 5113122531
Cash and cash equivalents 5113122531
Restricted cash and investments 00 2  
Receivables   1 00
Prepaid expense    111
Deferred costs    000
Other current assets 10  00
Other undisclosed current assets    000
Total current assets: 6113152732
Noncurrent Assets
Property, plant and equipment 000555
Intangible assets, net (including goodwill)    0(1)4
Goodwill     (1)2
Intangible assets, net (excluding goodwill)    002
Deferred costs     00
Other noncurrent assets    100
Other undisclosed noncurrent assets     1 
Total noncurrent assets: 0006610
TOTAL ASSETS: 6113213242
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 111899
Accounts payable 100321
Accrued liabilities 101654
Employee-related liabilities     23
Accounts payable and other accrued liabilities1
Debt    150
Deferred revenue and credits  000
Other undisclosed current liabilities 3   (2)0
Total current liabilities: 51110119
Noncurrent Liabilities
Long-term debt and lease obligation   09109
Long-term debt, excluding current maturities   09109
Capital lease obligations   000
Liabilities, other than long-term debt 000222
Deferred revenue and credits  222
Deferred tax liabilities, net     0
Other liabilities    0  
Derivative instruments and hedges, liabilities 000   
Other undisclosed noncurrent liabilities   (1)136
Total noncurrent liabilities: 00(0)121517
Total liabilities: 510222727
Temporary equity, carrying amount  11   
Stockholders' equity
Stockholders' equity attributable to parent, including: 1102(0)615
Common stock 000111
Treasury stock, value (3)(1)    
Additional paid in capital 333014455425402
Accumulated other comprehensive income    000
Accumulated deficit (28)(21)(13)(457)(420)(388)
Other undisclosed stockholders' equity attributable to parent  1    
Other undisclosed stockholders' equity   1   
Total stockholders' equity: 1102(0)615
TOTAL LIABILITIES AND EQUITY: 6113213242

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues    0 1
Revenue, net    1
Cost of revenue
(Cost of Goods and Services Sold)
      (0)
Gross profit:    0 1
Operating expenses (7)510(37)(32)(29)
Other undisclosed operating income (loss) 14(11)  1 
Operating income (loss): 7(5)10(37)(31)(29)
Nonoperating income (expense) (0)  0(1)2
Foreign currency transaction loss, before tax (0)     
Other nonoperating income (expense)    0(0)0
Interest and debt expense  2(0)(1)(1)(1)
Other undisclosed income from continuing operations before equity method investments, income taxes    736654
Income (loss) from continuing operations: 7(3)10363326
Loss from discontinued operations     (0) 
Income (loss) before gain (loss) on sale of properties: 7(3)10363226
Other undisclosed net income 011    
Net income: 7810363226
Other undisclosed net loss attributable to parent (14)(15)(19)(73)(65)(53)
Net loss attributable to parent: (7)(8)(10)(36)(33)(26)
Preferred stock dividends and other adjustments (0)(2)4   
Other undisclosed net income available to common stockholders, basic 141511   
Net income (loss) available to common stockholders, basic: 766(36)(33)(26)
Interest on convertible debt  (0)(0)   
Net income (loss) available to common stockholders, diluted: 765(36)(33)(26)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income: 7810363226
Other comprehensive income      0
Other undisclosed comprehensive loss    (73)(65)(53)
Comprehensive income (loss), net of tax, attributable to parent: 7810(36)(33)(26)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: